| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1176/APPI.AJGP.13.10.844 |
| P698 | PubMed publication ID | 16223962 |
| P50 | author | Daniel A Weintraub | Q64767919 |
| Matthew B. Stern | Q67208124 | ||
| P433 | issue | 10 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 844-851 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | American Journal of Geriatric Psychiatry | Q15752426 |
| P1476 | title | Psychiatric complications in Parkinson disease | |
| P478 | volume | 13 |
| Q64274928 | A Non-Invasive Medical Device for Parkinson's Patients with Episodes of Freezing of Gait |
| Q40099576 | A Novel Approach to Treating Anxiety and Enhancing Executive Skills in an Older Adult with Parkinson's Disease. |
| Q50760462 | A short scale for evaluation of neuropsychiatric disorders in Parkinson's disease: first psychometric approach. |
| Q48407672 | An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease |
| Q35189606 | Assessing depression and factors possibly associated with depression during the course of Parkinson's disease. |
| Q64117076 | Attempted Suicide in a Parkinsonian Patient Treated with DBS of the VIM and High Dose Carbidopa-Levodopa |
| Q37187592 | Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study |
| Q34576574 | Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease |
| Q37579709 | Beyond tremor and rigidity: non-motor features of Parkinson's disease |
| Q34457767 | Clinical aspects of palliative care in advanced Parkinson's disease |
| Q41017873 | Clinically significant psychiatric symptoms among male carriers of the fragile X premutation, with and without FXTAS, and the mediating influence of executive functioning |
| Q35269306 | Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial |
| Q34198761 | Course of psychiatric symptoms and global cognition in early Parkinson disease |
| Q92224078 | Depression Screening from Voice Samples of Patients Affected by Parkinson's Disease |
| Q34442089 | Depression in Parkinson's Disease: Symptom Improvement and Residual Symptoms After Acute Pharmacologic Management |
| Q26798063 | Depressive symptoms in neurodegenerative diseases |
| Q36158448 | Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15) |
| Q33465315 | Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study |
| Q48377450 | Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study |
| Q34641123 | Geriatric depression and cognitive impairment |
| Q48280303 | Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study |
| Q37364337 | Mitochondrial dynamics in Parkinson's disease |
| Q46226006 | Monoamine transporter availability in Parkinson's disease patients with or without depression |
| Q37714081 | Neuropsychiatric symptoms in untreated Parkinson's disease |
| Q34660675 | Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis |
| Q37354604 | Prevalence of depression among older Americans: the Aging, Demographics and Memory Study. |
| Q35201060 | Prevalence of psychotic symptoms in a community-based Parkinson disease sample |
| Q37084012 | Suicidal and death ideation in Parkinson's disease |
| Q37371215 | Transcranial direct current stimulation and repetitive transcranial magnetic stimulation in consultation-liaison psychiatry. |
| Q33767361 | Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease |
| Q50890848 | rTMS treatment for depression in Parkinson's disease increases BOLD responses in the left prefrontal cortex. |
Search more.